Global rapid microbiology testing market is expected to reach $7.1 billion by 2027Global rapid microbiology testing market is valued approximately at $3.8 billion in 2020 and is anticipated to grow with a healthy growth rate of about 9.4% over the forecast period 2021-2027. Rapid microbiology testing refers to the methods and technologies that permit the user to receive results of microbiology test faster as compared to conventional culture-plate methods. Advantages of rapid microbiology testing include high throughput capabilities, ease of use, minimal training requirements, high sensitivity and specificity, easy interfacing capabilities with laboratory information management, etc. The global rapid microbiology testing market is being driven by increasing incidence of infectious diseases and cancer and increased funding for research and development. Furthermore, growth prospects in emerging countries will provide new opportunities for the global rapid microbiology testing industry. According to the American Cancer Society, 17.0 million new cases of cancer were witnessed in 2018 with 9.5 million deaths across the globe which is expected to reach 27.5 million new cases with 16.3 million deaths by 2040. Such increase in cancer cases is expected to increase the adoption of rapid microbiology testing to enhance the testing methods and is expected to drive the market growth during the forecast period. However, high capital investments and low cost-benefit ratio may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global rapid microbiology testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to factors such as prevalence of infectious disease, R&D funding, increased focus for early detection of diseases, etc. Europe is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to factors such as adoption of advanced microbial testing, technological advancements, etc. in the region.

Major market player included in this report are:
Abbott Laboratories, Inc.
Becton, Dickinson and Company
BioM?(C)rieux SA
Bruker Corporation
Charles River Laboratories International, Inc.
Danaher Corporation
Merck KGaA
NEOGEN Corporation
Thermo Fisher Scientific
Sartorius AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Instruments
Reagents and Kits
Consumables
By Method:
Growth-Based Rapid Microbiology Testing
Cellular component-Based Rapid Microbiology Testing
Nucleic Acid-Based Rapid Microbiology Testing
Viability-Based Rapid Microbiology Testing
By Application:
Clinical Disease Diagnostics
Food & Beverage testing
Pharmaceutical & Biological Drug Testing
Environmental Testing
Cosmetics and Personal Care Products Testing
Research Applications
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Rapid Microbiology Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors